Clarius Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Clarius Group, LLC

$1.39 Billion
Q2 2024

A detailed history of Clarius Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Clarius Group, LLC holds 657 shares of REGN stock, worth $684,685. This represents 0.05% of its overall portfolio holdings.

Number of Shares

657

Previous 677 2.95%

Holding current value

$684,685

Previous $651,000 5.99%

% of portfolio

0.05%

Previous 0.05%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 11, 2024	SELL	$883.2 - $1071.19 $17,664 - $21,423	-20 Reduced 2.95%	657 $690,000
Q1 2024 Apr 17, 2024	SELL	$902.69 - $993.35 $94,782 - $104,301	-105 Reduced 13.43%	677 $651,000
Q4 2023 Jan 29, 2024	SELL	$775.18 - $881.7 $9,302 - $10,580	-12 Reduced 1.51%	782 $686,000
Q3 2023 Oct 19, 2023	SELL	$692.45 - $844.37 $144,029 - $175,628	-208 Reduced 20.76%	794 $653,000
Q2 2023 Aug 09, 2023	BUY	$700.03 - $830.35 $14,700 - $17,437	21 Added 2.14%	1,002 $719,000
Q1 2023 Apr 17, 2023	BUY	$680.49 - $826.97 $21,775 - $26,463	32 Added 3.37%	981 $806,000
Q4 2022 Jan 25, 2023	BUY	$705.89 - $766.39 $82,589 - $89,667	117 Added 14.06%	949 $685,000
Q2 2022 Aug 10, 2022	BUY	$548.35 - $738.84 $23,030 - $31,031	42 Added 5.32%	832 $492,000
Q4 2021 Feb 02, 2022	BUY	$543.48 - $670.97 $45,108 - $55,690	83 Added 11.74%	790 $499,000
Q3 2021 Oct 18, 2021	BUY	$574.03 - $680.96 $25,257 - $29,962	44 Added 6.64%	707 $428,000
Q2 2021 Aug 06, 2021	SELL	$472.8 - $558.54 $1,891 - $2,234	-4 Reduced 0.6%	663 $370,000
Q1 2021 Apr 27, 2021	BUY	$446.73 - $548.2 $23,229 - $28,506	52 Added 8.46%	667 $316,000
Q4 2020 Jan 15, 2021	BUY	$478.3 - $607.98 $28,698 - $36,478	60 Added 10.81%	615 $297,000
Q3 2020 Oct 09, 2020	SELL	$544.75 - $658.21 $55,564 - $67,137	-102 Reduced 15.53%	555 $311,000
Q2 2020 Jul 08, 2020	BUY	$493.32 - $643.92 $324,111 - $423,055	657 New	657 $410,000

Others Institutions Holding REGN

# of Institutions

1,463

Shares Held

84.5M

Call Options Held

907K

Put Options Held

1.3M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $112B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Account

Clarius Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History